ESC 365 - Generalizability of the EAST-AFNET 4 trial: assessing outcomes of early rhythm-control therapy in patients with atrial fibrillation

ESC Premium Access

Generalizability of the EAST-AFNET 4 trial: assessing outcomes of early rhythm-control therapy in patients with atrial fibrillation

Session: Highlights from the Young in atrial fibrillation

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor J. Dickow (Hamburg, DE)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Doctor Jannis Dickow

Asklepios St. Georg Clinic, Hamburg (Germany)

1 presentation

0 follower

3 more presentations in this session

Acute change in parasympathetic cardiac innervation after pulmonary vein isolation by pulse-field and radiofrequency energy

Speaker: Doctor P. Stojadinovic (Prague, CZ)

The association of stroke rate with low density lipoprotein and statin exposure in patients with atrial fibrillation (AF)

Speaker: Doctor B. Shweikialrefaee (Toronto, CA)

Lower heart rates and beta-blockers are associated with new-onset atrial fibrillation

Speaker: Doctor N. Habel (Burlington, US)

Access the full session

Highlights from the Young in atrial fibrillation

Speakers: Doctor J. Dickow, Doctor P. Stojadinovic, Doctor B. Shweikialrefaee, Doctor N. Habel

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources